🇺🇸 Beclometasone in United States

1,720 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 294 reports (17.09%)
  2. Malaise — 194 reports (11.28%)
  3. Nausea — 193 reports (11.22%)
  4. Dizziness — 185 reports (10.76%)
  5. Headache — 177 reports (10.29%)
  6. Fatigue — 146 reports (8.49%)
  7. Diarrhoea — 142 reports (8.26%)
  8. Vomiting — 132 reports (7.67%)
  9. Pyrexia — 131 reports (7.62%)
  10. Pneumonia — 126 reports (7.33%)

Source database →

Beclometasone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in United States

Frequently asked questions

Is Beclometasone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Beclometasone in United States?

Imperial College London is the originator. The local marketing authorisation holder may differ — check the official source linked above.